Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0501 Transporter Info | ||||
| Gene Name | SLCO3A1 | ||||
| Protein Name | Organic anion transporting polypeptide 3A1 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs1517618 | ||||
| Site of GPD | chr15:92104415 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>A / G>C | ||||
| Minor Allele Frequency | G=0.1010/199 (Global) | ||||
| Allele G | Click to Show/Hide the Full List of Affected Drugs: 4 Drugs in Total | ||||
| Efavirenz | N.A. | Hyponatremia | Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. | [ 1] | |
| Lamivudine | N.A. | Hyponatremia | Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. | [ 1] | |
| Nevirapine | N.A. | Hyponatremia | Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. | [ 1] | |
| Zidovudine | N.A. | Hyponatremia | Allele G is not associated with increased resistance to efavirenz, lamivudine, nevirapine and zidovudine in people with HIV Infections as compared to allele C. | [ 1] | |
| Genetic Polymorphism | rs8027174 | ||||
| Site of GPD | chr15:91941607 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | G>T | ||||
| Minor Allele Frequency | G=0.9510/1882 (Global) | ||||
| Genotypes GT + TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Darunavir | N.A. | Hyponatremia | Genotypes GT + TT is associated with decreased clearance of darunavir in people with HIV Infections as compared to genotypes GG + TT. | [ 2] | |
| Genetic Polymorphism | rs4294800 | ||||
| Site of GPD | chr15:91917464 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | A>C / A>G / A>T | ||||
| Minor Allele Frequency | A=0.2650/524 (Global) | ||||
| Genotype AA | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Darunavir | N.A. | Hyponatremia | Genotype AA is associated with increased volume of distribution of darunavir in people with HIV Infections as compared to genotypes AG + GG. | [ 2] | |
| References | |||||
| 1 | ABCB1 and ABCC1 variants associated with virological failure of first-line protease inhibitors antiretroviral regimens in Northeast Brazil patients. J Clin Pharmacol. 2013 Dec;53(12):1286-93. | ||||
| 2 | Simultaneous pharmacogenetics-based population pharmacokinetic analysis of darunavir and ritonavir in HIV-infected patients. Clin Pharmacokinet. 2013 Jul;52(7):543-53. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.